Changes in mortality among US adults with COPD in two national cohorts recruited from 1971-1975 and 1988-1994

Chest

Volumn 141, Issue 1, 2012, Pages 101-110

  Ford, Earl S ^a   Mannino, David M ^c   Zhao, Guixiang ^a   Li, Chaoyang ^b   Croft, Janet B ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; SEX DIFFERENCE; UNITED STATES;

EID: 84855431143     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0472     Document Type: Article

References (31)

1. World Health Organization. The global burden of disease: 2004 update. World Health Organization Web site. http://www.who.int/healthinfo/global-burden- disease/GBD-report-2004update-full.pdf. Accessed January 7, 2011.
2. American Lung Association. State of lung disease in diverse communities 2010. American Lung Association Web site. http://www.lungusa.org/assets/ documents/publications/lung-disease-data/solddc-2010.pdf. Accessed January 7, 2011.
3. National Heart, Lung, and Blood Institute. Morbidity & mortality: 2009 chartbook on cardiovascular, lung, and blood diseases. National Heart, Lung, and Blood Institute Web site. http://www.nhlbi.nih.gov/resources/docs/ 2009-ChartBook.pdf. Accessed January 7, 2011.
4. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003;58(5):388-393. (Pubitemid 36560940)
5. Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med. 2006;100(1):115-122. (Pubitemid 43039873)
6. Centers for Disease Control and Prevention. NHEFS linked mortality file. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nchs/ data-access/data-linkage/mortality/nhefs-linkage.htm. Accessed January 7, 2011.
7. Centers for Disease Control and Prevention. NHANES III linked mortality file. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/ nchs/data-access/data-linkage/mortality/nhanes3-linkage.htm. Accessed January 7, 2011.
8. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med. 2003;114(9):758-762. (Pubitemid 36776358)
9. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med. 2003;254(6):540-547. (Pubitemid 37521850)
10. Eisner MD, Anthonisen N, Coultas D, et al.; Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693-718.
11. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mölken MP. Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Thorax. 2010;65(8):711-718.
12. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128(4):2068-2075.
13. Dobler CC, Wong KK, Marks GB. Associations between statins and COPD: a systematic review. BMC Pulm Med. 2009;9:32.
14. Schenkein JG, Nahm MH, Dransfield MT. Pneumococcal vaccination for patients with COPD: current practice and future directions. Chest. 2008;133(3):767-774. (Pubitemid 351367387)
15. Schembri S, Morant S, Winter JH, MacDonald TM. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax. 2009;64(7):567-572.
16. Jiménez-García R, Ariñez-Fernandez MC, Hernández-Barrera V, Garcia-Carballo MM, de Miguel AG, Carrasco-Garrido P. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain. J Infect. 2007;54(1):65-74. (Pubitemid 44932937)
17. Qaseem A, Snow V, Shekelle P, et al.; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007;147(9):633-638. (Pubitemid 351664484)
18. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease Web site. http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management. html. Updated 2010. Accessed November 1, 2011.
19. Cranston JM, Crockett AJ, Moss JR, Alpers JH. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;(4):CD001744.
20. Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939-943.
21. Puhan MA, Scharplatz M, Troosters T, Steurer J. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality - a systematic review. Respir Res. 2005;6:54.
22. Peytremann-Bridevaux I, Staeger P, Bridevaux PO, Ghali WA, Burnand B. Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med. 2008;121(5):433-443.
23. Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Inhaled corticosteroids vs placebo for preventing COPD exacerbations: a systematic review and metaregression of randomized controlled trials. Chest. 2010;137(2):318-325.
24. Walters JA, Gibson PG, Wood-Baker R, Hannay M, Walters EH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2009;(1):CD001288.
25. Quon BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2008;133(3):756-766. (Pubitemid 351367386)
26. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest. 2001;119(6):1691-1695. (Pubitemid 32744923)
27. van Haren-Willems J, Heijdra Y. Increasing evidence for gender differences in chronic obstructive pulmonary disease. Womens Health (Lond Engl). 2010;6(4):595-600.
28. Hurst JR, Vestbo J, Anzueto A, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128-1138.
29. Sørheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 2010;65(6):480-485.
30. Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med. 2011;105(3):477-484.
31. Mannino DM, Holguin F, Pavlin BI, Ferdinands JM. Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up. Int J Tuberc Lung Dis. 2005;9(6):613-621. (Pubitemid 40826152)